Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00465725 · ClinicalTrials.gov registry record · Phase 1

A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors

A Phase 1 study of Breast Cancer and Prostate Cancer, sponsored by Poniard Pharmaceuticals.

Completed
Registry status
Phase 1
Development phase
18
Enrollment target
3
Study locations

NCT00465725 is a Phase 1 study of Breast Cancer and Prostate Cancer that has completed, run by Poniard Pharmaceuticals. The registered enrollment target is 18 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00465725, a Phase 1 study of Breast Cancer and Prostate Cancer, has completed, sponsored by Poniard Pharmaceuticals.

COMPLETED
Registry status
Phase 1
Development phase
18 participants
Enrollment target
3
Study locations

Study Summary

Picoplatin is a new platinum-based chemotherapy drug that has been studied in a variety of cancers. Phase 1 and 2 studies have demonstrated that picoplatin may be effective in patients whose cancer returns or does not improve after treatment with chemotherapy. In these studies, picoplatin was administered intravenously. A capsule containing picoplatin has been formulated. This study will investigate the activity of the oral capsule in humans. Participants with advanced solid tumors will be enrolled.

Conditions Studied

Breast Cancer Prostate Cancer Lung Cancer Colorectal Cancer Ovarian Cancer Pancreatic Cancer Head and Neck Cancer Bladder Cancer Gastrointestinal Neoplasm

Interventions

  • DRUG Picoplatin

Study Locations (3)

Georgia

  • Georgia Cancer Specialists - Atlanta

Nevada

  • Nevada Cancer Institute - Las Vegas

Washington

  • Northwest Medical Specialties - Tacoma

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2007-04
Est. Completion 2009-07
Phase Phase 1

Sponsor

Poniard Pharmaceuticals

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00465725

The ClinicalTrials.gov registry entry for NCT00465725 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Poniard Pharmaceuticals, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 9 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Picoplatin is the first listed.

NCT00465725 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Georgia, Nevada, Washington.

Frequently Asked Questions

What is clinical trial NCT00465725 about?

NCT00465725 is a clinical study titled "A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors". Picoplatin is a new platinum-based chemotherapy drug that has been studied in a variety of cancers. Phase 1 and 2 studies have demonstrated that picoplatin may be effective in patients whose cancer returns or does not improve after treatment with chemotherapy. In these studies, picoplatin was admini...

What is the current status of trial NCT00465725?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2007-04. Estimated completion is 2009-07.

What conditions does trial NCT00465725 study?

This clinical trial studies the following conditions: Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Ovarian Cancer.

What interventions are being tested in trial NCT00465725?

The interventions under investigation include: Picoplatin (DRUG).

Who is sponsoring clinical trial NCT00465725?

This trial is sponsored by Poniard Pharmaceuticals, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00465725 being conducted?

This trial has 3 study locations across Georgia, Nevada, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Breast Cancer

All registered trials for this condition

Prostate Cancer

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.